The store will not work correctly when cookies are disabled.
2-(4-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)ethoxy)benzylidene)malononitrile
ID: ALA2296205
PubChem CID: 76309421
Max Phase: Preclinical
Molecular Formula: C20H14N4O2S
Molecular Weight: 374.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#CC(C#N)=Cc1ccc(OCCSc2nnc(-c3ccccc3)o2)cc1
Standard InChI: InChI=1S/C20H14N4O2S/c21-13-16(14-22)12-15-6-8-18(9-7-15)25-10-11-27-20-24-23-19(26-20)17-4-2-1-3-5-17/h1-9,12H,10-11H2
Standard InChI Key: QMBKDEJDYGUTAG-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
4.1230 -3.8975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9385 -3.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3454 -3.1942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9380 -2.4881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1195 -2.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7162 -3.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1626 -3.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6420 -3.8528 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4201 -3.6003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4190 -2.7820 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6402 -2.5315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1359 -3.9945 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.8354 -3.5720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8194 -2.7550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5189 -2.3326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2345 -2.7272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2452 -3.5421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9600 -3.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6605 -3.5141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6417 -2.6929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9264 -2.3021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3766 -3.9078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0756 -3.4844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7917 -3.8781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0584 -2.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0446 -1.8548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5045 -4.2718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
8 9 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 3 0
24 27 3 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 374.43 | Molecular Weight (Monoisotopic): 374.0837 | AlogP: 4.34 | #Rotatable Bonds: 7 |
Polar Surface Area: 95.73 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.88 | CX LogD: 3.88 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.34 | Np Likeness Score: -1.78 |
References
1. Deora GS, Karthikeyan C, Moorthy NSHN, Rathore V, Rawat AK, Tamrakar AK, Srivastava AK, Trivedi P. (2013) Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B, 22 (11): [10.1007/s00044-013-0528-1] |